DA7R: A 7-Letter Zip Code to Target PDAC
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and is among the most aggressive and still incurable cancers. Innovative and successful therapeutic strategies are extremely needed. Peptides represent a versatile and promising tool to achieve tumor targeting, tha...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/5/1508 |
_version_ | 1827740361426993152 |
---|---|
author | Sofia Parrasia Andrea Rossa Nicola Roncaglia Andrea Mattarei Claudia Honisch Ildikò Szabò Paolo Ruzza Lucia Biasutto |
author_facet | Sofia Parrasia Andrea Rossa Nicola Roncaglia Andrea Mattarei Claudia Honisch Ildikò Szabò Paolo Ruzza Lucia Biasutto |
author_sort | Sofia Parrasia |
collection | DOAJ |
description | Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and is among the most aggressive and still incurable cancers. Innovative and successful therapeutic strategies are extremely needed. Peptides represent a versatile and promising tool to achieve tumor targeting, thanks to their ability to recognize specific target proteins (over)expressed on the surface of cancer cells. A7R is one such peptide, binding neuropilin-1 (NRP-1) and VEGFR2. Since PDAC expresses these receptors, the aim of this study was to test if A7R-drug conjugates could represent a PDAC-targeting strategy. PAPTP, a promising mitochondria-targeted anticancer compound, was selected as the cargo for this proof-of-concept study. Derivatives were designed as prodrugs, using a bioreversible linker to connect PAPTP to the peptide. Both the retro-inverso (DA7R) and the head-to-tail cyclic (cA7R) protease-resistant analogs of A7R were tested, and a tetraethylene glycol chain was introduced to improve solubility. Uptake of a fluorescent DA7R conjugate, as well as of the PAPTP-DA7R derivative into PDAC cell lines was found to be related to the expression levels of NRP-1 and VEGFR2. Conjugation of DA7R to therapeutically active compounds or nanovehicles might allow PDAC-targeted drug delivery, improving the efficacy of the therapy and reducing off-target effects. |
first_indexed | 2024-03-11T03:24:49Z |
format | Article |
id | doaj.art-dd511a09a1bc4d9d9767886021e8dac5 |
institution | Directory Open Access Journal |
issn | 1999-4923 |
language | English |
last_indexed | 2024-03-11T03:24:49Z |
publishDate | 2023-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceutics |
spelling | doaj.art-dd511a09a1bc4d9d9767886021e8dac52023-11-18T02:52:35ZengMDPI AGPharmaceutics1999-49232023-05-01155150810.3390/pharmaceutics15051508DA7R: A 7-Letter Zip Code to Target PDACSofia Parrasia0Andrea Rossa1Nicola Roncaglia2Andrea Mattarei3Claudia Honisch4Ildikò Szabò5Paolo Ruzza6Lucia Biasutto7Department of Biology, University of Padova, Viale G. Colombo 3, 35131 Padova, ItalyDepartment of Chemical Sciences, University of Padova, Via F. Marzolo 1, 35131 Padova, ItalyDepartment of Chemical Sciences, University of Padova, Via F. Marzolo 1, 35131 Padova, ItalyDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, ItalyCNR Institute of Biomolecular Chemistry, Padua Unit, Via F. Marzolo 1, 35131 Padova, ItalyDepartment of Biology, University of Padova, Viale G. Colombo 3, 35131 Padova, ItalyCNR Institute of Biomolecular Chemistry, Padua Unit, Via F. Marzolo 1, 35131 Padova, ItalyCNR Neuroscience Institute, Padua Unit, Viale G. Colombo 3, 35131 Padova, ItalyPancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and is among the most aggressive and still incurable cancers. Innovative and successful therapeutic strategies are extremely needed. Peptides represent a versatile and promising tool to achieve tumor targeting, thanks to their ability to recognize specific target proteins (over)expressed on the surface of cancer cells. A7R is one such peptide, binding neuropilin-1 (NRP-1) and VEGFR2. Since PDAC expresses these receptors, the aim of this study was to test if A7R-drug conjugates could represent a PDAC-targeting strategy. PAPTP, a promising mitochondria-targeted anticancer compound, was selected as the cargo for this proof-of-concept study. Derivatives were designed as prodrugs, using a bioreversible linker to connect PAPTP to the peptide. Both the retro-inverso (DA7R) and the head-to-tail cyclic (cA7R) protease-resistant analogs of A7R were tested, and a tetraethylene glycol chain was introduced to improve solubility. Uptake of a fluorescent DA7R conjugate, as well as of the PAPTP-DA7R derivative into PDAC cell lines was found to be related to the expression levels of NRP-1 and VEGFR2. Conjugation of DA7R to therapeutically active compounds or nanovehicles might allow PDAC-targeted drug delivery, improving the efficacy of the therapy and reducing off-target effects.https://www.mdpi.com/1999-4923/15/5/1508pancreatic ductal adenocarcinoma (PDAC)A7R peptideneuropilin-1 (NRP-1)vascular endothelial growth factor receptor-2 (VEGFR2)PAPTP |
spellingShingle | Sofia Parrasia Andrea Rossa Nicola Roncaglia Andrea Mattarei Claudia Honisch Ildikò Szabò Paolo Ruzza Lucia Biasutto DA7R: A 7-Letter Zip Code to Target PDAC Pharmaceutics pancreatic ductal adenocarcinoma (PDAC) A7R peptide neuropilin-1 (NRP-1) vascular endothelial growth factor receptor-2 (VEGFR2) PAPTP |
title | DA7R: A 7-Letter Zip Code to Target PDAC |
title_full | DA7R: A 7-Letter Zip Code to Target PDAC |
title_fullStr | DA7R: A 7-Letter Zip Code to Target PDAC |
title_full_unstemmed | DA7R: A 7-Letter Zip Code to Target PDAC |
title_short | DA7R: A 7-Letter Zip Code to Target PDAC |
title_sort | da7r a 7 letter zip code to target pdac |
topic | pancreatic ductal adenocarcinoma (PDAC) A7R peptide neuropilin-1 (NRP-1) vascular endothelial growth factor receptor-2 (VEGFR2) PAPTP |
url | https://www.mdpi.com/1999-4923/15/5/1508 |
work_keys_str_mv | AT sofiaparrasia da7ra7letterzipcodetotargetpdac AT andrearossa da7ra7letterzipcodetotargetpdac AT nicolaroncaglia da7ra7letterzipcodetotargetpdac AT andreamattarei da7ra7letterzipcodetotargetpdac AT claudiahonisch da7ra7letterzipcodetotargetpdac AT ildikoszabo da7ra7letterzipcodetotargetpdac AT paoloruzza da7ra7letterzipcodetotargetpdac AT luciabiasutto da7ra7letterzipcodetotargetpdac |